All Pharma News
Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics

Aeglea BioTherapeutics Announces Name Change to Spyre Therapeutics
PR NEWSWIRE
27 Nov 2023
Share Share
Exclusive: Aeglea rebrands to Spyre, names new CEO in IBD race

Exclusive: Aeglea rebrands to Spyre, names new CEO in IBD race
Kyle LaHucik ENDPTS
27 Nov 2023
Share Share
Aeglea BioTherapeutics Announces Sale of Pegzilarginase to Immedica Pharma

Aeglea BioTherapeutics Announces Sale of Pegzilarginase to Immedica Pharma
PR NEWSWIRE
27 Jul 2023
Share Share
Aeglea sells off rare disease asset to Immedica for $15M

Aeglea sells off rare disease asset to Immedica for $15M
Gabrielle Masson FIERCE BIOTECH
27 Jul 2023
Share Share
Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics

Aeglea BioTherapeutics Announces Acquisition of Spyre Therapeutics
PR NEWSWIRE
22 Jun 2023
Share Share
Spyre, a new biotech spinout, launches via merger with Aeglea

Spyre, a new biotech spinout, launches via merger with Aeglea
BIOPHARMADIVE
21 Jun 2023
Share Share
Aeglea lays off more staff, seeks exit in face of rocky data

Aeglea lays off more staff, seeks exit in face of rocky data
James Waldron FIERCE BIOTECH
12 Apr 2023
Share Share
Aeglea`s layoffs curb spending, but cash crunch still on cards

Aeglea`s layoffs curb spending, but cash crunch still on cards
Nick Paul Taylor FIERCE BIOTECH
03 Mar 2023
Share Share
Aeglea BioTherapeutics Appoints Linda Neuman, M.D to Chief Medical Officer

Aeglea BioTherapeutics Appoints Linda Neuman, M.D to Chief Medical Officer
PRNEWSWIRE
15 Nov 2022
Share Share
Aeglea BioTherapeutics Reports Third Quarter 2022 Financial Results

Aeglea BioTherapeutics Reports Third Quarter 2022 Financial Results
PRNEWSWIRE
03 Nov 2022
Share Share